Patients should avoid food allergens when taking the drug, according to the FDA. Finally, the biosimilar agent can be used for patients with chronic spontaneous urticaria — ongoing unexplained ...

The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

Discover a study that compared the effectiveness of P043 versus omalizumab in managing uncontrolled allergic asthma.

Tiffany Meng, PharmD, an oncology pharmacist, UCSF Health, discusses how pharmacists help mitigate financial toxicity for ...

Biosimilars are successor products to biopharmaceutical drugs ... PharmiWeb.com is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we ...

Biosimilar Candidate CT-P42 in Diabetic Macular Edema ... PharmiWeb.com is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesMEDIA RELEASEFY 2024 net sales[1] of USD 10.4 billion, up by 9%[2] in ...

Biosimilars like SELARSDI provide cost-saving ... in combination with other biologic immunosuppressive agents or phototherapy has not been evaluated in clinical trials of psoriasis.

“Biosimilars like SELARSDI create opportunities ... in combination with other biologic immunosuppressive agents or phototherapy has not been evaluated in clinical trials of psoriasis.

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE FY 2024 net sales[1] of USD 10.4 billion, up by 9%[2] in constant currencies (+7% in USD); Q4 net sales of ...